These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21963739)

  • 1. A case of organizing pneumonia induced by tocilizumab.
    Ikegawa K; Hanaoka M; Ushiki A; Yamamoto H; Kubo K
    Intern Med; 2011; 50(19):2191-3. PubMed ID: 21963739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive Multifocal Leukoencephalopathy during Tocilizumab Treatment for Rheumatoid Arthritis.
    Anada M; Tohyama M; Oda Y; Kamoshima Y; Amino I; Nakano F; Miyazaki Y; Akimoto S; Minami N; Kikuchi S; Terae S; Niino M
    Intern Med; 2020 Aug; 59(16):2053-2059. PubMed ID: 32448834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.
    Tanaka E; Inoue E; Hoshi D; Shimizu Y; Kobayashi A; Sugimoto N; Shidara K; Sato E; Seto Y; Nakajima A; Momohara S; Taniguchi A; Yamanaka H
    Mod Rheumatol; 2015 Jul; 25(4):503-13. PubMed ID: 25547018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab for the treatment of rheumatoid arthritis.
    Tanaka T; Ogata A; Narazaki M
    Expert Rev Clin Immunol; 2010 Nov; 6(6):843-54. PubMed ID: 20979549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.
    Maini RN; Taylor PC; Szechinski J; Pavelka K; Bröll J; Balint G; Emery P; Raemen F; Petersen J; Smolen J; Thomson D; Kishimoto T;
    Arthritis Rheum; 2006 Sep; 54(9):2817-29. PubMed ID: 16947782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
    Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Pethö-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG
    Lancet; 2016 Jul; 388(10042):343-355. PubMed ID: 27287832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced hypereosinophilia related to tocilizumab therapy for rheumatoid arthritis.
    Morrisroe K; Wong M
    Rheumatology (Oxford); 2015 Nov; 54(11):2113-4. PubMed ID: 26224305
    [No Abstract]   [Full Text] [Related]  

  • 8. MS arising during Tocilizumab therapy for rheumatoid arthritis.
    Beauchemin P; Carruthers R
    Mult Scler; 2016 Feb; 22(2):254-6. PubMed ID: 26743640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [IL-6 blockade].
    Kaneko Y; Takeuchi T
    Nihon Rinsho; 2016 Jun; 74(6):963-7. PubMed ID: 27311186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series.
    Talotta R; Atzeni F; Batticciotto A; Ditto MC; Gerardi MC; Sarzi-Puttini P
    J Med Case Rep; 2018 Jun; 12(1):154. PubMed ID: 29859543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy.
    Nishimoto N; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Azuma J; Kishimoto T
    Mod Rheumatol; 2009; 19(1):12-9. PubMed ID: 18979150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Pasteurellosis in a Patient Treated With Tocilizumab for Rheumatoid Arthritis.
    Gastaldi R; Sicaud A; Gaudin P; Baillet A
    J Clin Rheumatol; 2017 Dec; 23(8):451-452. PubMed ID: 29189562
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tocilizumab in rheumatoid arthritis].
    Rueda Gotor J; Blanco Alonso R
    Reumatol Clin; 2011 Mar; 6S3():S29-32. PubMed ID: 21794769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
    Karsdal MA; Schett G; Emery P; Harari O; Byrjalsen I; Kenwright A; Bay-Jensen AC; Platt A
    Semin Arthritis Rheum; 2012 Oct; 42(2):131-9. PubMed ID: 22397953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of pulmonary nontuberculous mycobacteriosis induced by tocilizumab treatment for rheumatoid arthritis].
    Inayama M; Shinohara T; Hosokawa E; Machida H; Iwahara Y; Ogushi F
    Kansenshogaku Zasshi; 2011 Sep; 85(5):523-6. PubMed ID: 22117383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus Reactivation Induced Acute Hepatitis and Gastric Erosions in a Patient with Rheumatoid Arthritis under Treatment with an Anti-IL-6 Receptor Antibody, Tocilizumab.
    Komura T; Ohta H; Nakai R; Seishima J; Yamato M; Miyazawa M; Kaji K; Marukawa Y; Kagaya T; Kitagawa K; Kawashima A; Kaneko S; Unoura M
    Intern Med; 2016; 55(14):1923-7. PubMed ID: 27432105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal encephalopathy and autoimmune-mediated limbic encephalitis following tocilizumab therapy.
    Yamaguchi Y; Furukawa K; Yamamoto T; Takahashi Y; Tanaka K; Takahashi M
    Intern Med; 2014; 53(8):879-82. PubMed ID: 24739610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: LITHE study 2-year results.
    Fleischmann RM; Halland AM; Brzosko M; Burgos-Vargas R; Mela C; Vernon E; Kremer JM
    J Rheumatol; 2013 Feb; 40(2):113-26. PubMed ID: 23322466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocilizumab: A Review in Rheumatoid Arthritis.
    Scott LJ
    Drugs; 2017 Nov; 77(17):1865-1879. PubMed ID: 29094311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoas abscess during treatment with intravenous tocilizumab in a patient with rheumatoid arthritis: a case-based review.
    Vajdić ID; Štimac G; Pezelj I; Mustapić M; Grazio S
    Rheumatol Int; 2021 Apr; 41(4):819-825. PubMed ID: 33576887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.